BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27237805)

  • 1. Discovery of a gamma heavy chain disease in a patient followed-up for a lymphoplasma cell proliferative disorder.
    Humeau C; Monjanel H; Schellenberg F
    Ann Biol Clin (Paris); 2016 Jun; 74(3):338-40. PubMed ID: 27237805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma heavy chain disease in a patient with underlying lymphoplasmacytic lymphoma of the thyroid. Report of a case and comparison with other reported cases with thyroid involvement.
    Tan JN; Kroll MH; O'Hara CJ; Everett PC; Erdogan E
    Clin Chim Acta; 2012 Oct; 413(19-20):1696-9. PubMed ID: 22561184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-heavy chain disease: review of 23 cases.
    Wahner-Roedler DL; Witzig TE; Loehrer LL; Kyle RA
    Medicine (Baltimore); 2003 Jul; 82(4):236-50. PubMed ID: 12861101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential development of Waldenström's macroglobulinemia and gamma-1-heavy chain disease in a single patient. Clinical, immunochemical, immunofluorescent and protein studies.
    Ockhuizen T; Jilderda JF; Cazemier T
    Acta Haematol; 1984; 71(1):53-9. PubMed ID: 6419527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heavy chain disease. Report of four cases].
    Silva-Moreno M; Ruiz-Arguelles GJ; Lopez-Karpovitch X; Labardini-Mendez J
    Sangre (Barc); 1983; 28(1):89-98. PubMed ID: 6408748
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal free light chains can be found in heavy chain diseases.
    López-Anglada L; Puig N; Díez-Campelo M; Alonso-Ralero L; Barrena S; Aparicio MA; Gutiérrez NC; García-Sanz R
    Ann Clin Biochem; 2010 Nov; 47(Pt 6):570-2. PubMed ID: 20930031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heavy chain disease. A case of IgG-heavy-chain-fragment and IgM-type K-paraproteinemia with plasma cell leukemia].
    Keller H; Spengler GA; Skvaril F; Flury W; Noseda G; Riva G
    Schweiz Med Wochenschr; 1970 Jun; 100(24):1012-22. PubMed ID: 5004028
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heavy chain disease. A case of IgG-heavy-chain-fragment and IgM-type-K-paraproteinemia with plasma cell leukemia].
    Keller H; Spengler GA; Skvaril F; Flury W; Noseda G; Riva G
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:133-4. PubMed ID: 5001748
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of γ-heavy-chain disease with rituximab and fludarabine.
    Inoue D; Matsushita A; Kiuchi M; Takiuchi Y; Nagano S; Arima H; Mori M; Tabata S; Yamashiro A; Maruoka H; Oita T; Imai Y; Takahashi T
    Acta Haematol; 2012; 128(3):139-43. PubMed ID: 22890122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Principal characteristics of heavy chain diseases].
    Seligmann M
    Bull Cancer; 1972; 59(4):381-8. PubMed ID: 4201934
    [No Abstract]   [Full Text] [Related]  

  • 11. Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases.
    Bieliauskas S; Tubbs RR; Bacon CM; Eshoa C; Foucar K; Gibson SE; Kroft SH; Sohani AR; Swerdlow SH; Cook JR
    Am J Surg Pathol; 2012 Apr; 36(4):534-43. PubMed ID: 22301495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects and therapy of Waldenström's disease and H-chain diseases].
    Scheurlen PG
    Verh Dtsch Ges Inn Med; 1975; 81():929-38. PubMed ID: 820118
    [No Abstract]   [Full Text] [Related]  

  • 13. Heavy chain diseases.
    Wahner-Roedler DL; Kyle RA
    Best Pract Res Clin Haematol; 2005; 18(4):729-46. PubMed ID: 16026747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined features of mu-heavy chain disease and primary macroglobulinemia in a single patient: clinical and immunological studies].
    Fujii H; Shimizu T; Seki S; Isemura T; Yamamoto K; Kanoh T; Ohno Y
    Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):622-32. PubMed ID: 6814143
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal IgM cryoglobulinemia associated with gamma-3 heavy chain disease: immunochemical and biochemical studies.
    Wang AC; Arnaud P; Fudenberg HH; Creyssel R
    Eur J Immunol; 1978 Jun; 8(6):375-9. PubMed ID: 97087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma heavy-chain disease accompanied with follicular lymphoma: a case report.
    San-José P; Aguadero V; Perea G; Estrada M; Berlanga E
    Biochem Med (Zagreb); 2018 Feb; 28(1):010802. PubMed ID: 29472805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heavy chain diseases].
    Seligmann M
    Rev Prat; 1993 Feb; 43(3):317-20. PubMed ID: 8502962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu-heavy chain disease associated with systemic amyloidosis.
    Kinoshita K; Yamagata T; Nozaki Y; Sugiyama M; Ikoma S; Funauchi M; Kanamaru A
    Hematology; 2004 Apr; 9(2):135-7. PubMed ID: 15203869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diverse picture of gamma heavy-chain disease. Report of seven cases and review of literature.
    Kyle RA; Greipp PR; Banks PM
    Mayo Clin Proc; 1981 Jul; 56(7):439-51. PubMed ID: 6789012
    [No Abstract]   [Full Text] [Related]  

  • 20. Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia.
    Gnemmi V; Leleu X; Provot F; Moulonguet F; Buob D
    Am J Kidney Dis; 2012 Sep; 60(3):487-91. PubMed ID: 22721930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.